Journals Journal of Endocrinological In...

Journal of Endocrinological Investigation
L Beduleva, A Sidorov, K Fomina, A Terentiev, I Menshikov, N Shklyaeva, P Ivanov, V Varaksin
PURPOSE: Hashimoto's thyroiditis (HT) is an autoimmune thyroid disease characterized by T lymphocyte-mediated destruction of thyroid follicles. To study the pathogenesis of HT and the efficacy of new substances for its treatment, an easily obtained and adequate to the human disease experimental model is needed. The aim of our study was to find out whether it is possible to induce experimental autoimmune thyroiditis (EAT) similar to Hashimoto's thyroiditis by injecting with thyroglobulin (Tg) without using agents that enhance its thyroiditogenicity and without taking into account the genetic sensitivity of animals...
November 27, 2023: Journal of Endocrinological Investigation
X Chen, X Shui, H Xu, J Peng, H Deng, J Zhong, C Wang, J Wu, J Yan, B Yao, Z Xiong, W Xu, X Yang
BACKGROUND: The incidence of preserved ejection fraction heart failure has significantly increased in persons with type 2 diabetes mellitus (T2DM). Left ventricular (LV) diastolic dysfunction is an early and important manifestation of preserved ejection fraction heart failure. The onset of heart failure in persons with diabetes is associated with diabetic neuropathy. However, the relationship among sudomotor function, which is an early manifestation of small fiber neuropathy, and LV diastolic function remains unclear...
November 24, 2023: Journal of Endocrinological Investigation
Ç Keskin, E N A Dilekçi, A Y Üçgül, R K Üçgül, G Toprak, D Cengiz
BACKGROUND: Today, limited and controversial data are available on predictive markers for diabetic retinopathy. Choroidal thickness (CT) is an unstable parameter affected by many factors. Also, previous studies had conflicting findings on choroidal thickness. In this study, we aimed to investigate the role of choroidal vascularity index (CVI), a relatively new marker, in evaluating choroidal vascular status and its relationship with diabetic retinopathy (DR). MATERIALS AND METHODS: A total of 124 subjects, 84 patients with type 2 diabetes mellitus (DM) and 40 healthy controls, were included in the study...
November 22, 2023: Journal of Endocrinological Investigation
G I Baroncelli, M R Sessa, C Pelosini, S Bertelloni, A Michelucci, B Toschi, P Piaggi, D Peroni, P Comberiati
OBJECTIVE: FGF23 measurement may have a diagnostic role to investigate patients with phosphate disorders. However, normal values for infants, children, and adolescents have not been defined. METHODS: In a total of 282 (males 145, females 137) healthy infants (n = 30), prepubertal (n = 147), pubertal (n = 59), and postpubertal (n = 46), and in twenty patients with X-linked hypophosphatemic rickets (XLH, age 10...
November 22, 2023: Journal of Endocrinological Investigation
V Zamponi, J Haxhi, G Pugliese, A Faggiano, R Mazzilli
PURPOSE: The aim of this review is to evaluate the effects of new technology used in the management of diabetes mellitus (DM), including the use of continuous glucose monitoring (CGM) and the administration of insulin through continuous subcutaneous insulin infusion (CSII), on male and female sexual function. METHODS: This narrative review was performed for all available prospective, retrospective and review articles, published up to June 2023 in PubMed. Data were extracted from the text and from the tables of the manuscript...
November 21, 2023: Journal of Endocrinological Investigation
F Giorgini, G Di Dalmazi, S Diciotti
BACKGROUND AND AIM: Artificial intelligence (AI) has emerged as a promising technology in the field of endocrinology, offering significant potential to revolutionize the diagnosis, treatment, and management of endocrine disorders. This comprehensive review aims to provide a concise overview of the current landscape of AI applications in endocrinology and metabolism, focusing on the fundamental concepts of AI, including machine learning algorithms and deep learning models. METHODS: The review explores various areas of endocrinology where AI has demonstrated its value, encompassing screening and diagnosis, risk prediction, translational research, and "pre-emptive medicine"...
November 16, 2023: Journal of Endocrinological Investigation
F Folli, L Centofanti, S Magnani, E Tagliabue, M Bignotto, L La Sala, A E Pontiroli
BACKGROUND AND AIMS: The role of overweight and obesity in the development of atrial fibrillation (AF) is well established; however, the differential effect on the occurrence and recurrence of AF remains uncertain. The aim of this review is to compare the effect of underweight and varying degrees of obesity on onset of AF and in recurrent post-ablation AF, and, when possible, in relation to sex. METHODS: A systematic literature search was conducted in PubMed, Embase, and Cochrane Library from inception to January 31, 2023...
November 14, 2023: Journal of Endocrinological Investigation
V Pena-Leon, R Perez-Lois, M Villalon, C Folgueira, S Barja-Fernández, E Prida, J Baltar, F Santos, J Fernø, T García-Caballero, R Nogueiras, M Quiñones, O Al-Massadi, L M Seoane
AIM: Growth differentiation factor 15 (GDF15) is a stress response cytokine that has been proposed as a relevant metabolic hormone. Descriptive studies have shown that plasma GDF15 levels are regulated by short term changes in nutritional status, such as fasting, or in obesity. However, few data exist regarding how GDF15 levels are regulated in peripheral tissues. The aim of the present work was to study the variations on gastric levels of GDF15 and its precursor under different physiological conditions, such as short-term changes in nutritional status or overfeeding achieved by HFD...
November 13, 2023: Journal of Endocrinological Investigation
W Liang, F F Sun
PURPOSE: In recent years, epidemiological studies have revealed the relationship between gestational diabetes mellitus (GDM) and cardiovascular disease (CVD). In this study, we utilized Mendelian randomization (MR) to investigate the potential causal impact of GDM on cardiovascular disease for the first time. METHODS:  We retrieved summary statistics from published genome-wide association studies. MR was first performed using significant SNPs extracted from the eighth data release of the FinnGen study...
November 12, 2023: Journal of Endocrinological Investigation
D G Z Guerrero, M A M Stumpf, A L S Monteiro, A Glezer
PURPOSE: To assess the effect of letrozole, an aromatase inhibitor (AI), in patients with resistant prolactinoma that presented an increase in serum prolactin (PRL) levels during testosterone replacement therapy (TRT). METHODS: A retrospective cohort study in a single tertiary care center. From March 2012 to July 2023, 53 male patients over 18 years with prolactinoma were followed in our Neuroendocrine Unit. Of those, 90.6% presented macroadenomas, 41% of them were resistant to cabergoline and 25% presented persistent hypogonadism to whom TRT was indicated...
November 8, 2023: Journal of Endocrinological Investigation
S Aksun, N C Sonu, S Aygun, U N Karakulak, S Mumusoglu, B O Yildiz
PURPOSE: Cardiometabolic risk factors are common in women with polycystic ovary syndrome (PCOS) during reproductive years. The aim of this study was to determine the impact of aging on cardiometabolic risk of the syndrome by examining women who had previously been diagnosed to have PCOS or to be healthy in an unselected population in 2009. PARTICIPANTS: Forty-one women with PCOS who were diagnosed and phenotyped according to the Rotterdam criteria and 43 age- and body mass index (BMI)-matched healthy women from the same unselected cohort...
November 6, 2023: Journal of Endocrinological Investigation
I Matias, E W Lehmann, P Zizzari, S Byberg, D Cota, S S Torekov, C Quarta
OBJECTIVE: N-acylethanolamines (NAEs) include endocannabinoid (EC) and EC-related molecules that impact the anti-obesity and anti-diabetic efficacy of glucagon-like peptide-1 receptor agonists (GLP-1RA) in animal studies. However, the clinical relevance of these findings remains to be determined. Here, we tested whether GLP-1RA treatment affects circulating NAE levels and whether NAEs may predict the efficacy of GLP-1RA treatment in humans with obesity undergoing weight loss maintenance...
November 4, 2023: Journal of Endocrinological Investigation
G Porcu, A Biffi, R Ronco, G Adami, R Alvaro, R Bogini, A P Caputi, B Frediani, D Gatti, S Gonnelli, G Iolascon, A Lenzi, S Leone, R Michieli, S Migliaccio, T Nicoletti, M Paoletta, A Pennini, E Piccirilli, M Rossini, U Tarantino, L Cianferotti, M L Brandi, G Corrao
PURPOSE: Since vertebral fragility fractures (VFFs) might increase the risk of subsequent fractures, we evaluated the incidence rate and the refracture risk of subsequent vertebral and non-vertebral fragility fractures (nVFFs) in untreated patients with a previous VFF. METHODS: We systematically searched PubMed, Embase, and Cochrane Library up to February 2022 for randomized clinical trials (RCTs) that analyzed the occurrence of subsequent fractures in untreated patients with prior VFFs...
November 3, 2023: Journal of Endocrinological Investigation
F Fruzzetti, T Fidecicchi, E Benelli, F Baldari, M Tonacchera
AIM: To assess which parameters among hyperandrogenism (total testosterone-tT-or free androgen index-FAI), sex hormone binding globulin (SHBG) or body mass index (BMI) could better predict a worse metabolic profile in women with polycystic ovary syndrome (PCOS). METHODS: Five hundred and eighty-six women with PCOS and clinical or biochemical hyperandrogenism were included. Receiver Operating Characteristics (ROC) curves with tT, FAI, SHBG and BMI were performed for metabolic parameters and a cut-off with sensitivity and specificity was obtained for each parameter...
October 31, 2023: Journal of Endocrinological Investigation
S Liu, H Sun, S Yang, N Liang, Y Gao, S Qu, H Chen
OBJECTIVES: To study the aggregation of multiple comorbidities in people with gout and explore differences in prognosis of gout flares among different subgroups. METHODS: Hierarchical clustering was performed to identify homogeneous subgroups among 2639 people with gout using eight comorbidities. A one-year follow-up of acute gout flares in 463 of these people was conducted; the incidence and the timing of gout flares in each cluster were assessed to explore prognosis of gout flares...
October 31, 2023: Journal of Endocrinological Investigation
A Arecco, S Ottaviani, M Boschetti, P Renzetti, L Marinelli
No abstract text is available yet for this article.
October 29, 2023: Journal of Endocrinological Investigation
V Sada, G Puliani, T Feola, R Pirchio, R Pofi, F Sesti, D De Alcubierre, M E Amodeo, F D'Aniello, L Vincenzi, D Gianfrilli, A M Isidori, A B Grossman, E Sbardella
PURPOSE: Tall stature is defined as height greater than the threshold of more than 2 standard deviations above the average population height for age, sex, and ethnicity. Many studies have described the main aspects of this condition during puberty, but an analysis of the characteristics that the physician should consider in the differential diagnosis of gigantism-tall stature secondary to a pituitary tumour-during the transition age (15-25 years) is still lacking. METHODS: A comprehensive search of English-language original articles was conducted in the MEDLINE database (December 2021-March 2022)...
October 27, 2023: Journal of Endocrinological Investigation
D Santi, G Spaggiari, L Marinelli, M Cacciani, S Scipio, A Bichiri, A Profeta, A R M Granata, M Simoni, F Lanfranco, C Manieri, E Ghigo, G Motta
PURPOSE: Gender-affirming hormone treatment (GAHT) is one of the main demands of transgender and gender diverse (TGD) people, who are usually categorised as transgender assigned-male-at birth (AMAB) and assigned-female-at birth (AFAB). The aim of the study is to investigate the long-term therapeutic management of GAHT, considering hormonal targets, treatment adjustments and GAHT safety. METHODS: A retrospective, longitudinal, observational, multicentre clinical study was carried out...
October 27, 2023: Journal of Endocrinological Investigation
D Norello, G Rastrelli, L Antonio, G Bartfai, F F Casanueva, A Giwercman, I T Huhtaniemi, T W O'Neill, M Punab, J Slowikowska-Hilczer, J Tournoy, D Vanderschueren, F C W Wu, M Maggi, A Peri
OBJECTIVE: To determine the influence of serum sodium on physical, psychologic and sexual function. METHODS: This is a cross-sectional survey on 3340 community-dwelling men aged 40-79 years from a prospective cohort study in eight European countries, the European Male Ageing Study (EMAS). Participants filled-out the Short Form-36 (SF-36), the Physical Activity Scale for the Elderly (PASE), and the EMAS sexual function questionnaire. For all the analyses, serum sodium corrected for glycaemia ([Na+ ]G ) was used...
October 26, 2023: Journal of Endocrinological Investigation
E Vitali, G Valente, A Panzardi, A Laffi, A Zerbi, S Uccella, G Mazziotti, A Lania
PURPOSE: The finding of mTOR overactivation in patients affected by pancreatic neuroendocrine tumors (Pa-NETs) led to their treatment with the mTOR inhibitor everolimus. Unfortunately, the efficacy of everolimus is restricted by the occurrence of resistance. The mechanisms leading to Pa-NETs' progression and resistance are not well understood. Notably, chronic inflammation is implicated in NET development. NF-kB is involved in inflammation and drug resistance mechanisms through the activation of several mediators, including STAT3...
October 26, 2023: Journal of Endocrinological Investigation
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read

Save your favorite articles in one place with a free QxMD account.


Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.